Population
Patients with bone and soft-tissue tumors/sarcomas (e.g., osteosarcoma)
Design
Review
Authors
Loading...
Supports molecular subtyping in sarcomas; leaves open whether targeted therapies improve outcomes.
Molecular testing with PCR and FISH enables accurate diagnosis of chromosomal translocations in sarcomas, highlighting potential future therapeutic targets.
Wustrack et al. (2016) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: